I wish you well.
I attach a link to trials on fats and Sjogren's Syndrome
It looks as if your fat intake may have implications for the condition - see posts on this site re balancing omega threes and sixes. Fish oils seems according to the trial below to improve the risk of the condition. This would make sense as inflamatory factors are involved as they are with BC. Could be a double positive - oh and arthritis too.
Please do consult with your advisor. You may wish to print out the trials to discuss with him or her.
RB
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=search&term=Sjogren's+Syn drome+fats
AND SPECIFICALY
http://www.ncbi.nlm.nih.gov/entrez/q...=pubmed_docsum
1: Prostaglandins Leukot Essent Fatty Acids. 1998 Oct;59(4):239-45. Related Articles, Links
Essential fatty acid status in cell membranes and plasma of patients with primary Sjogren's syndrome. Correlations to clinical and immunologic variables using a new model for classification and assessment of disease manifestations.
Oxholm P, Asmussen K, Wiik A, Horrobin DF.
Copenhagen Sjogren's Syndrome Research Centre, Department of Rheumatology U, Copenhagen County Hospital in Gentofte, Hellerup, Denmark.
peter.oxholm@dadlnet.dk
In 41 primary Sjogren's syndrome patients we compared fatty acid levels within erythrocyte phospholipids, plasma phospholipids, plasma triglycerides and plasma cholesterol esters, with the immunopathological and clinical disease status. Docosahexaenoic acid was the essential fatty acid (EFA), the levels of which correlated (inversely) most closely with the clinical disease status (r=-0.33 to -0.50). Levels of dihomogammalinolenic acid and eicosapentaenoic acid correlated inversely to levels of IgM rheumatoid factors (r=-0.33) and anti-SSA/Ro antibodies (r=-0.40) respectively. Moreover, levels of anti-SSA/Ro antibodies (r=-0.34-0.40) correlated with levels of the proinflammatory arachidonic acid. Sigma n-3 EFA/sigma n-6 EFA ratios correlated significantly to the quantitative estimates of immunopathological and clinical disease status. Our data are in agreement with current understanding of pro- and anti-immunoinflammatory roles within EFA metabolism, and support the rationale for intervention studies.
PMID: 9849649 [PubMed - indexed for MEDLINE]